Re-evaluation of established risk scores by measurement of nucleated red blood cells in blood of surgical intensive care patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 65, Issue 3, 2008, Pages 666-673

  Stachon, Axel ^a,b   Becker, Andreas ^a   Kempf, Reiner ^a   Holland Letz, Tim ^c   Friese, Jochen ^b   Krieg, Michael ^a  

^a Institute of Clinical Chemistry   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

APACHE II; In hospital mortality; Nucleated red blood cells; SAPS II

Indexed keywords

ADULT; AGED; ANALYZER; APACHE; AREA UNDER THE CURVE; ARTICLE; BLOOD; CELL SCREENING; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CYTOMETRY; DEATH; ERYTHROCYTE; EVALUATION; FEASIBILITY STUDY; FEMALE; HUMAN; INTENSIVE CARE; LOGISTIC REGRESSION ANALYSIS; MALE; MODEL; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK; SCORING SYSTEM; SURGICAL PATIENT; ADOLESCENT; ERYTHROBLAST; ERYTHROCYTE COUNT; HEALTH SURVEY; INJURY; MIDDLE AGED; PREDICTION AND FORECASTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ERYTHROBLASTS; ERYTHROCYTE COUNT; FEMALE; HEALTH STATUS INDICATORS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; WOUNDS AND INJURIES;

EID: 67650329830     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318181e524     Document Type: Article

References (32)

1. Budmiger H, Graf C, Streuli RA. The leukoerythroblastic blood picture. Incidence and clinical significance. Schweiz Rundsch Med Prax. 1984;73:1489-1493.
2. Mettier SR. Hematologic aspects of space consuming lesions of the bone marrow (myelophtisic anemia). Ann Intern Med. 1940;14:436-448.
3. Schwartz SO, Stansbury F. Significance of nucleated red blood cells in peripheral blood. JAMA. 1954;154:1339-1340.
4. Delsol G, Guiu-Godfrin B, Guiu M, Pris J, Corberand J, Fabre J. Leukoerythroblastosis and cancer frequency, prognosis, and physiopathologic significance. Cancer. 1979;44:1009 -1013.
5. Weick JK, Hagedorn AB, Linman JW. Leukoerythroblastosis. Diagnostic and prognostic significance. Mayo Clin Proc. 1974; 49:110-113.
6. Tavassoli M. Erythroblastemia. West J Med. 1975;122:194-198.
7. Andres WA. Normoblastemia after thermal injury. Am J Surg. 1976; 131:725-726.
8. Böning A, Stachon A, Weisser H, et al. Postoperative cholesterol and erythroblasts as a parameter of perioperative mortality after cardiothoracic surgery. Z Herz Thorax Gefaesschir. 2001;15:242-248.
9. Stachon A, Böning A, Krismann M, et al. Prognostic significance of erythroblasts in blood after cardiothoracic surgery. Clin Chem Lab Med. 2001;39:239-243.
10. Briggs C, Harrison P, Grant D, Staves J, MacHin SJ. New quantitative parameters on recently introduced automated blood cell counter - the XE 2100TM. Clin Lab Haematol. 2000;22:345-350.
11. Walters J, Garrity P. Performance evaluation of the Sysmex XE-2100 hematology analyser. Lab Hematol. 2000;6:83-92.
12. Stachon A, Sondermann N, Krieg M. Incidence of nucleated red blood cells in the blood of hospitalised patients. Infusion Ther Transfus Med. 2001;28:263-266.
13. Stachon A, Sondermann N, Imöhl M, Krieg M. Nucleated red blood cells indicate high risk for in-hospital mortality. J Lab Clin Med. 2002;140:407-412.
14. Stachon A, Kempf R, Holland-Letz T, Friese J, Becker A, Krieg M. Daily monitoring of nucleated red blood cells in the blood of surgical intensive care patients. Clin Chim Acta. 2006;366:329-335.
15. Stachon A, Holland-Letz T, Krieg M. High in-hospital mortality of intensive care patients with nucleated red blood cells in blood. Clin Chem Lab Med. 2004;42:933-938.
16. Stachon A, Eisenblätter K, Köller M, Holland-Letz T, Krieg M. Cytokines and erythropoietin in the blood of patients with erythroblastemia. Acta Haematol. 2003;110:204-206.
17. Stachon A, Bolulu O, Holland-Letz T, Krieg M. Association between nucleated red blood cells in blood and the levels of erythropoietin, interleukin-3, interleukin-6, and interleukin-12p70. Shock. 2005;24:34-39.
18. Stachon A, Holland-Letz T, Kempf R, Becker A, Friese J, Krieg M. Poor prognosis indicated by nucleated red blood cells in peripheral blood is not associated with organ failure of the liver or kidney. Clin Chem Lab Med. 2006;44:955-961.
19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13:818-829.
20. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957-2963.
21. Rosenberg AL. Recent innovations in intensive care unit risk-prediction models. Curr Opin Crit Care. 2002;8:321-330.
22. Ruzicka K, Veitl M, Thalhammer-Scherrer R, Schwarzinger I. The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology. Arch Pathol Lab Med. 2001;125:391-396.
23. Lehnhardt M, Katzy Y, Langer S, et al. Prognostic significance of erythroblasts in burns. Plast Reconstr Surg. 2005;115:120-127.
24. West CD, Ley AB, Pearson OH. Myelophthisic anemia in cancer of the breast. Am J Med. 1955;18:923-931.
25. Otsubo H, Kaito K, Asai O, Usui N, Kobayashi M, Hoshi Y. Persistent nucleated red blood cells in peripheral blood is a poor prognostic factor in patients undergoing stem cell transplantation. Clin Lab Haematol. 2005;27:242-246.
26. Clifford GO. The clinical significance of leukoerythroblastic anemia. Med Clin North Am. 1966;50:779-790.
27. Higgins TL. Quantifying risk and assessing outcome in cardiac surgery. J Cardiothorac Vasc Anesth. 1998;12:330-340.
28. Stachon A, Lehnhardt M, Katzy Y, Holland-Letz T, Steinau HU, Krieg M. Making the case for adapting the abbreviated burn severity index to include erythroblast count. J Wound Care. 2005;14:97-100.
29. Del Bufalo C, Morelli A, Bassein L, et al. Severity scores in respiratory intensive care: APACHE II predicted mortality better than SAPS II. Respir Care. 1995;40:1042-1047.
30. Harrison DA, Brady AR, Parry GJ, Carpenter JR, Rowan K. Recalibration of risk prediction models in a large multicenter cohort of admissions to adult, general critical care units in the United Kingdom. Crit Care Med. 2006;34:1378-1388.
31. Muckart DJ, Bhagwanjee S, Gouws E. Validation of an outcome prediction model for critically ill trauma patients without head injury. J Trauma. 1997;43:934-938.
32. Schetz MR, Van den Berghe G. Do we have reliable biochemical markers to predict the outcome of critical illness? Int J Artific Org. 2005;28:1197-1210.